(5Z)-5-[(6-Bromo-2H-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione

Catalog No.: 
ACEAVR474
CAS No.: 
58215-52-4
Molecular Formula: 
C11H6BrNO4S
Molecular Weight: 
328.14
(5Z)-5-[(6-Bromo-2H-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$109.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1599.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(5Z)-5-[(6-Bromo-2H-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione
IUPAC Name(Z)-5-((6-bromobenzo[d][1,3]dioxol-5-yl)methylene)thiazolidine-2,4-dione
MDL No.MFCD02186494
Molecular FormulaC11H6BrNO4S
Molecular Weight328.14
SMILESO=C(NC/1=O)SC1=C/C2=C(Br)C=C(OCO3)C3=C2
InChI KeyZKYVGMMEWZRAPH-MBXJOHMKSA-N
Synonym5-[(Z)-(6-BROMO-1,3-BENZODIOXOL-5-YL)METHYLIDENE]-1,3-THIAZOLANE-2,4-DIONE;(5Z)-5-[(6-bromo-2H-1,3-benzodioxol-5-yl)methylidene]-1,3-thiazolidine-2,4-dione;2,4-Thiazolidinedione, 5-[(6-bromo-1,3-benzodioxol-5-yl)methylene]-, (Z)- (9CI)
CAS No.58215-52-4

Synthetic Route by SureRoute

1. ACEAVR474 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOFNI502 route compound structure diagram
    ACOFNI5022295-31-0In Stock
  2. Plus
  3. ACVJWY924 route compound structure diagram
    ACVJWY92415930-53-7In Stock
  4. Then
  5. ACEAVR474 route product structure diagram
    ACEAVR47458215-52-4
Inquiry

2. ACEAVR474 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEAVR474 route product structure diagram
    ACEAVR47458215-52-4
Inquiry

3. ACEAVR474 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEAVR474 route product structure diagram
    ACEAVR47458215-52-4
Inquiry

Comments (0)